Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Functional Foods Beverage Market

ID: MRFR/FnB/25252-HCR
128 Pages
Harshita Gorde
Last Updated: April 16, 2026

Functional Foods And Beverage Market Size, Share, Industry Trend & Analysis Research Report By Type (Dairy Foods, BakeryCereals, Food Drinks, Snacks, Dietary Supplements), By Health (Cardiovascular Health, Digestive Health, Immune Health, Metabolic Health, Brain Health), By Form (Fortified, Enhanced, Natural, Organic, Pharmaceutical), By Source (Plant-based, Animal-based, Algae-based, Synthetic, Bioengineered) andBy Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa)- Forecast to 2035.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Functional Foods Beverage Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Food, Beverages & Nutrition, BY Type (USD Billion)
  49.     4.1.1 Dairy Foods
  50.     4.1.2 Bakery Cereals
  51.     4.1.3 Food Drinks
  52.     4.1.4 Snacks
  53.     4.1.5 Dietary Supplements
  54.   4.2 Food, Beverages & Nutrition, BY Health (USD Billion)
  55.     4.2.1 Cardiovascular Health
  56.     4.2.2 Digestive Health
  57.     4.2.3 Immune Health
  58.     4.2.4 Metabolic Health
  59.     4.2.5 Brain Health
  60.   4.3 Food, Beverages & Nutrition, BY Form (USD Billion)
  61.     4.3.1 Fortified
  62.     4.3.2 Enhanced
  63.     4.3.3 Natural
  64.     4.3.4 Organic
  65.     4.3.5 Pharmaceutical
  66.   4.4 Food, Beverages & Nutrition, BY Source (USD Billion)
  67.     4.4.1 Plant-based
  68.     4.4.2 Animal-based
  69.     4.4.3 Algae-based
  70.     4.4.4 Synthetic
  71.     4.4.5 Bioengineered
  72.   4.5 Food, Beverages & Nutrition, BY Region (USD Billion)
  73.     4.5.1 North America
  74.       4.5.1.1 US
  75.       4.5.1.2 Canada
  76.     4.5.2 Europe
  77.       4.5.2.1 Germany
  78.       4.5.2.2 UK
  79.       4.5.2.3 France
  80.       4.5.2.4 Russia
  81.       4.5.2.5 Italy
  82.       4.5.2.6 Spain
  83.       4.5.2.7 Rest of Europe
  84.     4.5.3 APAC
  85.       4.5.3.1 China
  86.       4.5.3.2 India
  87.       4.5.3.3 Japan
  88.       4.5.3.4 South Korea
  89.       4.5.3.5 Malaysia
  90.       4.5.3.6 Thailand
  91.       4.5.3.7 Indonesia
  92.       4.5.3.8 Rest of APAC
  93.     4.5.4 South America
  94.       4.5.4.1 Brazil
  95.       4.5.4.2 Mexico
  96.       4.5.4.3 Argentina
  97.       4.5.4.4 Rest of South America
  98.     4.5.5 MEA
  99.       4.5.5.1 GCC Countries
  100.       4.5.5.2 South Africa
  101.       4.5.5.3 Rest of MEA
  102. 5 SECTION V: COMPETITIVE ANALYSIS
  103.   5.1 Competitive Landscape
  104.     5.1.1 Overview
  105.     5.1.2 Competitive Analysis
  106.     5.1.3 Market share Analysis
  107.     5.1.4 Major Growth Strategy in the Food, Beverages & Nutrition
  108.     5.1.5 Competitive Benchmarking
  109.     5.1.6 Leading Players in Terms of Number of Developments in the Food, Beverages & Nutrition
  110.     5.1.7 Key developments and growth strategies
  111.       5.1.7.1 New Product Launch/Service Deployment
  112.       5.1.7.2 Merger & Acquisitions
  113.       5.1.7.3 Joint Ventures
  114.     5.1.8 Major Players Financial Matrix
  115.       5.1.8.1 Sales and Operating Income
  116.       5.1.8.2 Major Players R&D Expenditure. 2023
  117.   5.2 Company Profiles
  118.     5.2.1 Nestle (CH)
  119.       5.2.1.1 Financial Overview
  120.       5.2.1.2 Products Offered
  121.       5.2.1.3 Key Developments
  122.       5.2.1.4 SWOT Analysis
  123.       5.2.1.5 Key Strategies
  124.     5.2.2 PepsiCo (US)
  125.       5.2.2.1 Financial Overview
  126.       5.2.2.2 Products Offered
  127.       5.2.2.3 Key Developments
  128.       5.2.2.4 SWOT Analysis
  129.       5.2.2.5 Key Strategies
  130.     5.2.3 Coca-Cola (US)
  131.       5.2.3.1 Financial Overview
  132.       5.2.3.2 Products Offered
  133.       5.2.3.3 Key Developments
  134.       5.2.3.4 SWOT Analysis
  135.       5.2.3.5 Key Strategies
  136.     5.2.4 Danone (FR)
  137.       5.2.4.1 Financial Overview
  138.       5.2.4.2 Products Offered
  139.       5.2.4.3 Key Developments
  140.       5.2.4.4 SWOT Analysis
  141.       5.2.4.5 Key Strategies
  142.     5.2.5 General Mills (US)
  143.       5.2.5.1 Financial Overview
  144.       5.2.5.2 Products Offered
  145.       5.2.5.3 Key Developments
  146.       5.2.5.4 SWOT Analysis
  147.       5.2.5.5 Key Strategies
  148.     5.2.6 Kraft Heinz (US)
  149.       5.2.6.1 Financial Overview
  150.       5.2.6.2 Products Offered
  151.       5.2.6.3 Key Developments
  152.       5.2.6.4 SWOT Analysis
  153.       5.2.6.5 Key Strategies
  154.     5.2.7 Unilever (GB)
  155.       5.2.7.1 Financial Overview
  156.       5.2.7.2 Products Offered
  157.       5.2.7.3 Key Developments
  158.       5.2.7.4 SWOT Analysis
  159.       5.2.7.5 Key Strategies
  160.     5.2.8 Abbott Laboratories (US)
  161.       5.2.8.1 Financial Overview
  162.       5.2.8.2 Products Offered
  163.       5.2.8.3 Key Developments
  164.       5.2.8.4 SWOT Analysis
  165.       5.2.8.5 Key Strategies
  166.     5.2.9 Mondelez International (US)
  167.       5.2.9.1 Financial Overview
  168.       5.2.9.2 Products Offered
  169.       5.2.9.3 Key Developments
  170.       5.2.9.4 SWOT Analysis
  171.       5.2.9.5 Key Strategies
  172.   5.3 Appendix
  173.     5.3.1 References
  174.     5.3.2 Related Reports
  175. 6 LIST OF FIGURES
  176.   6.1 MARKET SYNOPSIS
  177.   6.2 NORTH AMERICA MARKET ANALYSIS
  178.   6.3 US MARKET ANALYSIS BY TYPE
  179.   6.4 US MARKET ANALYSIS BY HEALTH
  180.   6.5 US MARKET ANALYSIS BY FORM
  181.   6.6 US MARKET ANALYSIS BY SOURCE
  182.   6.7 CANADA MARKET ANALYSIS BY TYPE
  183.   6.8 CANADA MARKET ANALYSIS BY HEALTH
  184.   6.9 CANADA MARKET ANALYSIS BY FORM
  185.   6.10 CANADA MARKET ANALYSIS BY SOURCE
  186.   6.11 EUROPE MARKET ANALYSIS
  187.   6.12 GERMANY MARKET ANALYSIS BY TYPE
  188.   6.13 GERMANY MARKET ANALYSIS BY HEALTH
  189.   6.14 GERMANY MARKET ANALYSIS BY FORM
  190.   6.15 GERMANY MARKET ANALYSIS BY SOURCE
  191.   6.16 UK MARKET ANALYSIS BY TYPE
  192.   6.17 UK MARKET ANALYSIS BY HEALTH
  193.   6.18 UK MARKET ANALYSIS BY FORM
  194.   6.19 UK MARKET ANALYSIS BY SOURCE
  195.   6.20 FRANCE MARKET ANALYSIS BY TYPE
  196.   6.21 FRANCE MARKET ANALYSIS BY HEALTH
  197.   6.22 FRANCE MARKET ANALYSIS BY FORM
  198.   6.23 FRANCE MARKET ANALYSIS BY SOURCE
  199.   6.24 RUSSIA MARKET ANALYSIS BY TYPE
  200.   6.25 RUSSIA MARKET ANALYSIS BY HEALTH
  201.   6.26 RUSSIA MARKET ANALYSIS BY FORM
  202.   6.27 RUSSIA MARKET ANALYSIS BY SOURCE
  203.   6.28 ITALY MARKET ANALYSIS BY TYPE
  204.   6.29 ITALY MARKET ANALYSIS BY HEALTH
  205.   6.30 ITALY MARKET ANALYSIS BY FORM
  206.   6.31 ITALY MARKET ANALYSIS BY SOURCE
  207.   6.32 SPAIN MARKET ANALYSIS BY TYPE
  208.   6.33 SPAIN MARKET ANALYSIS BY HEALTH
  209.   6.34 SPAIN MARKET ANALYSIS BY FORM
  210.   6.35 SPAIN MARKET ANALYSIS BY SOURCE
  211.   6.36 REST OF EUROPE MARKET ANALYSIS BY TYPE
  212.   6.37 REST OF EUROPE MARKET ANALYSIS BY HEALTH
  213.   6.38 REST OF EUROPE MARKET ANALYSIS BY FORM
  214.   6.39 REST OF EUROPE MARKET ANALYSIS BY SOURCE
  215.   6.40 APAC MARKET ANALYSIS
  216.   6.41 CHINA MARKET ANALYSIS BY TYPE
  217.   6.42 CHINA MARKET ANALYSIS BY HEALTH
  218.   6.43 CHINA MARKET ANALYSIS BY FORM
  219.   6.44 CHINA MARKET ANALYSIS BY SOURCE
  220.   6.45 INDIA MARKET ANALYSIS BY TYPE
  221.   6.46 INDIA MARKET ANALYSIS BY HEALTH
  222.   6.47 INDIA MARKET ANALYSIS BY FORM
  223.   6.48 INDIA MARKET ANALYSIS BY SOURCE
  224.   6.49 JAPAN MARKET ANALYSIS BY TYPE
  225.   6.50 JAPAN MARKET ANALYSIS BY HEALTH
  226.   6.51 JAPAN MARKET ANALYSIS BY FORM
  227.   6.52 JAPAN MARKET ANALYSIS BY SOURCE
  228.   6.53 SOUTH KOREA MARKET ANALYSIS BY TYPE
  229.   6.54 SOUTH KOREA MARKET ANALYSIS BY HEALTH
  230.   6.55 SOUTH KOREA MARKET ANALYSIS BY FORM
  231.   6.56 SOUTH KOREA MARKET ANALYSIS BY SOURCE
  232.   6.57 MALAYSIA MARKET ANALYSIS BY TYPE
  233.   6.58 MALAYSIA MARKET ANALYSIS BY HEALTH
  234.   6.59 MALAYSIA MARKET ANALYSIS BY FORM
  235.   6.60 MALAYSIA MARKET ANALYSIS BY SOURCE
  236.   6.61 THAILAND MARKET ANALYSIS BY TYPE
  237.   6.62 THAILAND MARKET ANALYSIS BY HEALTH
  238.   6.63 THAILAND MARKET ANALYSIS BY FORM
  239.   6.64 THAILAND MARKET ANALYSIS BY SOURCE
  240.   6.65 INDONESIA MARKET ANALYSIS BY TYPE
  241.   6.66 INDONESIA MARKET ANALYSIS BY HEALTH
  242.   6.67 INDONESIA MARKET ANALYSIS BY FORM
  243.   6.68 INDONESIA MARKET ANALYSIS BY SOURCE
  244.   6.69 REST OF APAC MARKET ANALYSIS BY TYPE
  245.   6.70 REST OF APAC MARKET ANALYSIS BY HEALTH
  246.   6.71 REST OF APAC MARKET ANALYSIS BY FORM
  247.   6.72 REST OF APAC MARKET ANALYSIS BY SOURCE
  248.   6.73 SOUTH AMERICA MARKET ANALYSIS
  249.   6.74 BRAZIL MARKET ANALYSIS BY TYPE
  250.   6.75 BRAZIL MARKET ANALYSIS BY HEALTH
  251.   6.76 BRAZIL MARKET ANALYSIS BY FORM
  252.   6.77 BRAZIL MARKET ANALYSIS BY SOURCE
  253.   6.78 MEXICO MARKET ANALYSIS BY TYPE
  254.   6.79 MEXICO MARKET ANALYSIS BY HEALTH
  255.   6.80 MEXICO MARKET ANALYSIS BY FORM
  256.   6.81 MEXICO MARKET ANALYSIS BY SOURCE
  257.   6.82 ARGENTINA MARKET ANALYSIS BY TYPE
  258.   6.83 ARGENTINA MARKET ANALYSIS BY HEALTH
  259.   6.84 ARGENTINA MARKET ANALYSIS BY FORM
  260.   6.85 ARGENTINA MARKET ANALYSIS BY SOURCE
  261.   6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE
  262.   6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY HEALTH
  263.   6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY FORM
  264.   6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY SOURCE
  265.   6.90 MEA MARKET ANALYSIS
  266.   6.91 GCC COUNTRIES MARKET ANALYSIS BY TYPE
  267.   6.92 GCC COUNTRIES MARKET ANALYSIS BY HEALTH
  268.   6.93 GCC COUNTRIES MARKET ANALYSIS BY FORM
  269.   6.94 GCC COUNTRIES MARKET ANALYSIS BY SOURCE
  270.   6.95 SOUTH AFRICA MARKET ANALYSIS BY TYPE
  271.   6.96 SOUTH AFRICA MARKET ANALYSIS BY HEALTH
  272.   6.97 SOUTH AFRICA MARKET ANALYSIS BY FORM
  273.   6.98 SOUTH AFRICA MARKET ANALYSIS BY SOURCE
  274.   6.99 REST OF MEA MARKET ANALYSIS BY TYPE
  275.   6.100 REST OF MEA MARKET ANALYSIS BY HEALTH
  276.   6.101 REST OF MEA MARKET ANALYSIS BY FORM
  277.   6.102 REST OF MEA MARKET ANALYSIS BY SOURCE
  278.   6.103 KEY BUYING CRITERIA OF FOOD, BEVERAGES & NUTRITION
  279.   6.104 RESEARCH PROCESS OF MRFR
  280.   6.105 DRO ANALYSIS OF FOOD, BEVERAGES & NUTRITION
  281.   6.106 DRIVERS IMPACT ANALYSIS: FOOD, BEVERAGES & NUTRITION
  282.   6.107 RESTRAINTS IMPACT ANALYSIS: FOOD, BEVERAGES & NUTRITION
  283.   6.108 SUPPLY / VALUE CHAIN: FOOD, BEVERAGES & NUTRITION
  284.   6.109 FOOD, BEVERAGES & NUTRITION, BY TYPE, 2024 (% SHARE)
  285.   6.110 FOOD, BEVERAGES & NUTRITION, BY TYPE, 2024 TO 2035 (USD Billion)
  286.   6.111 FOOD, BEVERAGES & NUTRITION, BY HEALTH, 2024 (% SHARE)
  287.   6.112 FOOD, BEVERAGES & NUTRITION, BY HEALTH, 2024 TO 2035 (USD Billion)
  288.   6.113 FOOD, BEVERAGES & NUTRITION, BY FORM, 2024 (% SHARE)
  289.   6.114 FOOD, BEVERAGES & NUTRITION, BY FORM, 2024 TO 2035 (USD Billion)
  290.   6.115 FOOD, BEVERAGES & NUTRITION, BY SOURCE, 2024 (% SHARE)
  291.   6.116 FOOD, BEVERAGES & NUTRITION, BY SOURCE, 2024 TO 2035 (USD Billion)
  292.   6.117 BENCHMARKING OF MAJOR COMPETITORS
  293. 7 LIST OF TABLES
  294.   7.1 LIST OF ASSUMPTIONS
  295.     7.1.1
  296.   7.2 North America MARKET SIZE ESTIMATES; FORECAST
  297.     7.2.1 BY TYPE, 2025-2035 (USD Billion)
  298.     7.2.2 BY HEALTH, 2025-2035 (USD Billion)
  299.     7.2.3 BY FORM, 2025-2035 (USD Billion)
  300.     7.2.4 BY SOURCE, 2025-2035 (USD Billion)
  301.   7.3 US MARKET SIZE ESTIMATES; FORECAST
  302.     7.3.1 BY TYPE, 2025-2035 (USD Billion)
  303.     7.3.2 BY HEALTH, 2025-2035 (USD Billion)
  304.     7.3.3 BY FORM, 2025-2035 (USD Billion)
  305.     7.3.4 BY SOURCE, 2025-2035 (USD Billion)
  306.   7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  307.     7.4.1 BY TYPE, 2025-2035 (USD Billion)
  308.     7.4.2 BY HEALTH, 2025-2035 (USD Billion)
  309.     7.4.3 BY FORM, 2025-2035 (USD Billion)
  310.     7.4.4 BY SOURCE, 2025-2035 (USD Billion)
  311.   7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  312.     7.5.1 BY TYPE, 2025-2035 (USD Billion)
  313.     7.5.2 BY HEALTH, 2025-2035 (USD Billion)
  314.     7.5.3 BY FORM, 2025-2035 (USD Billion)
  315.     7.5.4 BY SOURCE, 2025-2035 (USD Billion)
  316.   7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  317.     7.6.1 BY TYPE, 2025-2035 (USD Billion)
  318.     7.6.2 BY HEALTH, 2025-2035 (USD Billion)
  319.     7.6.3 BY FORM, 2025-2035 (USD Billion)
  320.     7.6.4 BY SOURCE, 2025-2035 (USD Billion)
  321.   7.7 UK MARKET SIZE ESTIMATES; FORECAST
  322.     7.7.1 BY TYPE, 2025-2035 (USD Billion)
  323.     7.7.2 BY HEALTH, 2025-2035 (USD Billion)
  324.     7.7.3 BY FORM, 2025-2035 (USD Billion)
  325.     7.7.4 BY SOURCE, 2025-2035 (USD Billion)
  326.   7.8 France MARKET SIZE ESTIMATES; FORECAST
  327.     7.8.1 BY TYPE, 2025-2035 (USD Billion)
  328.     7.8.2 BY HEALTH, 2025-2035 (USD Billion)
  329.     7.8.3 BY FORM, 2025-2035 (USD Billion)
  330.     7.8.4 BY SOURCE, 2025-2035 (USD Billion)
  331.   7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  332.     7.9.1 BY TYPE, 2025-2035 (USD Billion)
  333.     7.9.2 BY HEALTH, 2025-2035 (USD Billion)
  334.     7.9.3 BY FORM, 2025-2035 (USD Billion)
  335.     7.9.4 BY SOURCE, 2025-2035 (USD Billion)
  336.   7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  337.     7.10.1 BY TYPE, 2025-2035 (USD Billion)
  338.     7.10.2 BY HEALTH, 2025-2035 (USD Billion)
  339.     7.10.3 BY FORM, 2025-2035 (USD Billion)
  340.     7.10.4 BY SOURCE, 2025-2035 (USD Billion)
  341.   7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  342.     7.11.1 BY TYPE, 2025-2035 (USD Billion)
  343.     7.11.2 BY HEALTH, 2025-2035 (USD Billion)
  344.     7.11.3 BY FORM, 2025-2035 (USD Billion)
  345.     7.11.4 BY SOURCE, 2025-2035 (USD Billion)
  346.   7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  347.     7.12.1 BY TYPE, 2025-2035 (USD Billion)
  348.     7.12.2 BY HEALTH, 2025-2035 (USD Billion)
  349.     7.12.3 BY FORM, 2025-2035 (USD Billion)
  350.     7.12.4 BY SOURCE, 2025-2035 (USD Billion)
  351.   7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  352.     7.13.1 BY TYPE, 2025-2035 (USD Billion)
  353.     7.13.2 BY HEALTH, 2025-2035 (USD Billion)
  354.     7.13.3 BY FORM, 2025-2035 (USD Billion)
  355.     7.13.4 BY SOURCE, 2025-2035 (USD Billion)
  356.   7.14 China MARKET SIZE ESTIMATES; FORECAST
  357.     7.14.1 BY TYPE, 2025-2035 (USD Billion)
  358.     7.14.2 BY HEALTH, 2025-2035 (USD Billion)
  359.     7.14.3 BY FORM, 2025-2035 (USD Billion)
  360.     7.14.4 BY SOURCE, 2025-2035 (USD Billion)
  361.   7.15 India MARKET SIZE ESTIMATES; FORECAST
  362.     7.15.1 BY TYPE, 2025-2035 (USD Billion)
  363.     7.15.2 BY HEALTH, 2025-2035 (USD Billion)
  364.     7.15.3 BY FORM, 2025-2035 (USD Billion)
  365.     7.15.4 BY SOURCE, 2025-2035 (USD Billion)
  366.   7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  367.     7.16.1 BY TYPE, 2025-2035 (USD Billion)
  368.     7.16.2 BY HEALTH, 2025-2035 (USD Billion)
  369.     7.16.3 BY FORM, 2025-2035 (USD Billion)
  370.     7.16.4 BY SOURCE, 2025-2035 (USD Billion)
  371.   7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  372.     7.17.1 BY TYPE, 2025-2035 (USD Billion)
  373.     7.17.2 BY HEALTH, 2025-2035 (USD Billion)
  374.     7.17.3 BY FORM, 2025-2035 (USD Billion)
  375.     7.17.4 BY SOURCE, 2025-2035 (USD Billion)
  376.   7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  377.     7.18.1 BY TYPE, 2025-2035 (USD Billion)
  378.     7.18.2 BY HEALTH, 2025-2035 (USD Billion)
  379.     7.18.3 BY FORM, 2025-2035 (USD Billion)
  380.     7.18.4 BY SOURCE, 2025-2035 (USD Billion)
  381.   7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  382.     7.19.1 BY TYPE, 2025-2035 (USD Billion)
  383.     7.19.2 BY HEALTH, 2025-2035 (USD Billion)
  384.     7.19.3 BY FORM, 2025-2035 (USD Billion)
  385.     7.19.4 BY SOURCE, 2025-2035 (USD Billion)
  386.   7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  387.     7.20.1 BY TYPE, 2025-2035 (USD Billion)
  388.     7.20.2 BY HEALTH, 2025-2035 (USD Billion)
  389.     7.20.3 BY FORM, 2025-2035 (USD Billion)
  390.     7.20.4 BY SOURCE, 2025-2035 (USD Billion)
  391.   7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  392.     7.21.1 BY TYPE, 2025-2035 (USD Billion)
  393.     7.21.2 BY HEALTH, 2025-2035 (USD Billion)
  394.     7.21.3 BY FORM, 2025-2035 (USD Billion)
  395.     7.21.4 BY SOURCE, 2025-2035 (USD Billion)
  396.   7.22 South America MARKET SIZE ESTIMATES; FORECAST
  397.     7.22.1 BY TYPE, 2025-2035 (USD Billion)
  398.     7.22.2 BY HEALTH, 2025-2035 (USD Billion)
  399.     7.22.3 BY FORM, 2025-2035 (USD Billion)
  400.     7.22.4 BY SOURCE, 2025-2035 (USD Billion)
  401.   7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  402.     7.23.1 BY TYPE, 2025-2035 (USD Billion)
  403.     7.23.2 BY HEALTH, 2025-2035 (USD Billion)
  404.     7.23.3 BY FORM, 2025-2035 (USD Billion)
  405.     7.23.4 BY SOURCE, 2025-2035 (USD Billion)
  406.   7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  407.     7.24.1 BY TYPE, 2025-2035 (USD Billion)
  408.     7.24.2 BY HEALTH, 2025-2035 (USD Billion)
  409.     7.24.3 BY FORM, 2025-2035 (USD Billion)
  410.     7.24.4 BY SOURCE, 2025-2035 (USD Billion)
  411.   7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  412.     7.25.1 BY TYPE, 2025-2035 (USD Billion)
  413.     7.25.2 BY HEALTH, 2025-2035 (USD Billion)
  414.     7.25.3 BY FORM, 2025-2035 (USD Billion)
  415.     7.25.4 BY SOURCE, 2025-2035 (USD Billion)
  416.   7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  417.     7.26.1 BY TYPE, 2025-2035 (USD Billion)
  418.     7.26.2 BY HEALTH, 2025-2035 (USD Billion)
  419.     7.26.3 BY FORM, 2025-2035 (USD Billion)
  420.     7.26.4 BY SOURCE, 2025-2035 (USD Billion)
  421.   7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  422.     7.27.1 BY TYPE, 2025-2035 (USD Billion)
  423.     7.27.2 BY HEALTH, 2025-2035 (USD Billion)
  424.     7.27.3 BY FORM, 2025-2035 (USD Billion)
  425.     7.27.4 BY SOURCE, 2025-2035 (USD Billion)
  426.   7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  427.     7.28.1 BY TYPE, 2025-2035 (USD Billion)
  428.     7.28.2 BY HEALTH, 2025-2035 (USD Billion)
  429.     7.28.3 BY FORM, 2025-2035 (USD Billion)
  430.     7.28.4 BY SOURCE, 2025-2035 (USD Billion)
  431.   7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  432.     7.29.1 BY TYPE, 2025-2035 (USD Billion)
  433.     7.29.2 BY HEALTH, 2025-2035 (USD Billion)
  434.     7.29.3 BY FORM, 2025-2035 (USD Billion)
  435.     7.29.4 BY SOURCE, 2025-2035 (USD Billion)
  436.   7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  437.     7.30.1 BY TYPE, 2025-2035 (USD Billion)
  438.     7.30.2 BY HEALTH, 2025-2035 (USD Billion)
  439.     7.30.3 BY FORM, 2025-2035 (USD Billion)
  440.     7.30.4 BY SOURCE, 2025-2035 (USD Billion)
  441.   7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  442.     7.31.1
  443.   7.32 ACQUISITION/PARTNERSHIP
  444.     7.32.1

Food, Beverages & Nutrition Market Segmentation

Food, Beverages & Nutrition By Type (USD Billion, 2025-2035)

  • Dairy Foods
  • Bakery Cereals
  • Food Drinks
  • Snacks
  • Dietary Supplements

Food, Beverages & Nutrition By Health (USD Billion, 2025-2035)

  • Cardiovascular Health
  • Digestive Health
  • Immune Health
  • Metabolic Health
  • Brain Health

Food, Beverages & Nutrition By Form (USD Billion, 2025-2035)

  • Fortified
  • Enhanced
  • Natural
  • Organic
  • Pharmaceutical

Food, Beverages & Nutrition By Source (USD Billion, 2025-2035)

  • Plant-based
  • Animal-based
  • Algae-based
  • Synthetic
  • Bioengineered

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions